Although the detection of gene mutation status has been used as an important therapeutic strategy in the clinical treatment of a variety of tumors, the relationship between PIK3CA mutations and clinicopathological characteristics and prognosis of breast cancer patients is still controversial. This evidence concerns the gene PIK3CA and breast carcinoma.